Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07113223Not ApplicableRecruiting

Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)

Role: collaborator

NCT07255378Recruiting

Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication

Role: collaborator

NCT03434483Completed

The Microbiome as a Target for Precision Medicine in Atherosclerosis

Role: collaborator

NCT04739215Phase 4Unknown

Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF

Role: collaborator

NCT02970409Not ApplicableCompleted

Heparin Versus Saline in Peripheral Venous Catheter

Role: collaborator

NCT03183154Unknown

Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected

Role: collaborator

All 6 trials loaded